No. 133 (August 2020)
unsubscribe
REGISTER
to access members-only pages
on the APSR website
APSR News
Regional society news
Health news
Education
APSR Membership
Future Events
Contact

APSR News

APSR President-Elect
Call for nominations


Michiyoshi
Harasawa

Wan-Cheng
Tan

Wei-Ci
Luo

Ann Janet
Woolcock

Shiro
Kira

Wah-Kit
Lam

Yoshinosuke
Fukuchi

Norbert
Berend

YoungSoo
Shim

Mary S-M
Ip

Arth
Nana

Michiaki
Mishima

Kwun
Fong

Yoichi
Nakanishi

who do you
nominate
next?

Members are now invited to nominate the next APSR President-Elect. Self-nomination also possible.

The President-Elect's term is one year, from November 2020 to November 2021. Thereafter he or she will become APSR President for the next two years.

The deadline for receiving applications from nominees is 9 August 2020 so your nominations must be submitted very soon.

This is a unique chance for members to nominate who should lead the Society and also an opportunity to put themselves forward for the position.

Full details and how to nominate are at: apsresp.org/archive/president-elect-nominations-2020.html

New Respirology articles on the coronavirus

  • Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory state
    Cormac McCarthy, Stefano Savinelli, Eoin R Feeney, Marcus W Butler, Cathal O'Broin, Silke Ryan, Lorraine O'Neill, David J Murphy, Charles G Gallagher, Edward F McKone, Sarmad Waqas, Aoife Cotter, Peter Doran, Michael P Keane, Patrick W Mallon; DOI: 10.1111/resp.13912
    First published 21 July 2020
  • Universal public mask wear during COVID-19 pandemic: Rationale, design and acceptability
    Christopher Liu OBE, FRCOphth, FRCSEd, FRCP, CertLRS; Rawya Diab MBBS, MD, MRCSEd, FICO; Hasan Naveed MBBS, BSc (Hons); Victor Leung MSc, CIH, ROH, CRSP; DOI: 10.1111/resp.13892
    First published 6 July 2020
  • The challenge of COVID-19 has accelerated the use of new data-sharing technologies
    Venktesh R Ramnath MD; Kristina Kairaitis MD PhD; Atul Malhotra MD; DOI: 10.1111/resp.13894
    First published 1 July 2020

Recent Respirology Case Reports on the coronavirus

  • A case of non-severe COVID-19 complicated by pulmonary embolism
    Yuto Akiyama, Kohei Horiuchi, Yasushi Kondo, Hiroki Kabata, Makoto Ishii, Koichi Fukunaga
    DOI: 10.1002/rcr2.622
    First published 15 July 2020

More...

See a collection of COVID-19 material on the dedicated COVID-19 page on the APSR website.

Inside Respirology

Respirology Vol. 25 Issue 8

Show / Hide
page
EDITORIALS
776Anti-inflammatory reliever therapy in asthma: The evidence mounts but more is needed
Pepa Bruce MBBS; Lee Hatter MBBS; Richard Beasley DSc
10.1111/resp.13889
779Shedding light on the 'black hole' of small airways physiology in asthma
Francis Thien MD FRACP FCCP
10.1111/resp.13799
781From Osler to personalized medicine in obstructive airways disease
Nethmi Kearns MBChB; Ciléin Kearns MBChB; Richard Beasley DSc
10.1111/resp.13810
784Tumour mutation burden of non-small cell lung cancer with pre-existing ILD
Chong-Kin Liam MBBS, FRCP (London)
10.1111/resp.13750
787High attenuation areas in pulmonary computed tomography: Their meaning and use in interstitial lung disease
Kenneth K Lau MBBS, FRANZCR, EBIR; Dee Nandurkar MBBS, FRANZCR, FAANMS
10.1111/resp.13820
790The 'great wait' for diagnosis in pulmonary arterial hypertension
Jason Weatherald MD; Marc Humbert MD, PhD
10.1111/resp.13814
793Periodic leg movements: A marker of cardiovascular risk?
Mark E Howard MBBS, FRACP, GDEB, PhD; Fergal J O'Donoghue FRACP, PhD
10.1111/resp.13795
COMMENTARIES
795Inhaled corticosteroids/formoterol as a reliever in mild asthma
Paul M O'Byrne MB, FRCP(C)
10.1111/resp.13813
797Targeting the interleukin-17 pathway to prevent acute respiratory distress syndrome associated with SARS-CoV -2 infection
Tomas Raul Wiche Salinas MD, PhD(c); Boyang Zheng MD; Jean-Pierre Routy MD; Petronela Ancuta PhD
10.1111/resp.13875
800The challenge of COVID-19 has accelerated the use of new data-sharing technologies
Venktesh R Ramnath MD; Kristina Kairaitis MD, PhD; Atul Malhotra MD
10.1111/resp.13894
802Is it time to redefine obstructive sleep apnoea?
Sateesh Sakhamuri DM, FCCP, ATSF; Surujpal Teelucksingh FRCP (EDIN); Ahmed S BaHammam MD, FRCP
10.1111/resp.13880
INVITED REVIEWS
804What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?
Christine R Jenkins; Eric D Bateman; Malcolm R Sears; Paul M O'Byrne
10.1111/resp.13804
816Pulmonary alveolar proteinosis
Stéphane Jouneau; Cédric Ménard; Mathieu Lederlin
10.1111/resp.13831
ORIGINAL ARTICLES
Asthma and Allergy
827
Ventilation heterogeneity and oscillometry predict asthma control improvement following step-up inhaled therapy in uncontrolled asthma
Francesca S M Tang; Sandra Rutting; Catherine E Farrow; Katrina O Tonga; Joanna Watts; Jessica R Dame-Carrol; Amy Bertolin; Gregory G King; Cindy Thamrin; David G Chapman
10.1111/resp.13772

In the present study, we found that baseline measures of small airway function by forced oscillation technique (FOT) and multiple-breath nitrogen washout (MBNW) predicted improved asthma control upon inhaled corticosteroid (ICS) up-titration, suggesting that FOT and MBNW may provide important markers for assessing ICS responsiveness.

COPD
836
Identification and definition of asthma–COPD overlap: The CanCOLD study
Miriam Barrecheguren; Lancelot Pinto; Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi; Wan C Tan; Pei Z Li; Shawn D Aaron; Andrea Benedetti; Kenneth R Chapman; Brandie Walker; J Mark Fitzgerald; Paul Hernandez; François Maltais; Darcy D Marciniuk; Denis E O'Donnell; Don D Sin; Jean Bourbeau for the CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network
10.1111/resp.13780

Lack of consensus on the diagnosis of ACO limits our understanding of impact and outcomes. We identified individuals with ACO in the CanCOLD population by using seven clinical definitions. Asthma and atopy were the features that best identified ACO, and these patients had worse outcomes.

Interstitial Lung Disease
850Characterization of tumour mutation burden in patients with non-small cell lung cancer and interstitial lung disease
Haruki Kobayashi; Masakuni Serizawa; Tateaki Naito; Hayato Konno; Hideaki Kojima; Tetsuya Mizuno; Mitsuhiro Isaka; Masahiro Endo; Takeshi Nagashima; Masatoshi Kusuhara; Kenichi Urakami; Keiichi Ohshima; Ken Yamaguchi; Yasuhisa Ohde; Toshiaki Takahashi;
10.1111/resp.13726

Patients with NSCLC and ILD did not have high TMB and could develop severe pneumonitis if immune checkpoint inhibitors are used. Therefore, immune checkpoint inhibitors should not be used based on expectations of high TMB in patients with NSCLC and ILD.

855Reference values for high attenuation areas on chest CT in a healthy, never-smoker, multi-ethnic sample: The MESA study
Imaani Easthausen; Anna Podolanczuk; Eric Hoffman; Steven Kawut; Elizabeth Oelsner; John S Kim; Ganesh Raghu; Karen Hinckley Stukovsky; Susan Redline; Robyn L McClelland; R Graham Barr; David J Lederer
10.1111/resp.13783

To better understand the natural variation of HAA (a novel quantitative CT-based measure of subclinical ILD), we developed HAA reference equations and z-scores to define expected values of HAA with adjustment for key demographic and anthropometric variables, and we demonstrated that HAA z-scores correlate with several ILD features.

Pulmonary Vascular Disease
863Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry
Victor Khou; James J Anderson; Geoff Strange; Carolyn Corrigan; Nicholas Collins; David S Celermajer; Nathan Dwyer; John Feenstra; Mark Horrigan; Dominic Keating; Eugene Kotlyar; Melanie Lavender; Tanya J McWilliams; Peter Steele; Robert Weintraub; Helen Whitford; Ken Whyte ;Trevor J Williams; Jeremy P Wrobel; Anne Keogh; Edmund M Lau
10.1111/resp.13768

We examined diagnostic delay in a large binational cohort of PAH patients. Mean and median diagnostic intervals were 2.5+/–4.1 and 1.2 (IQR: 0.6–2.7) years, respectively. Age, cardiovascular and respiratory comorbidities were associated with longer diagnostic interval. Mortality was increased in patients with greater diagnostic interval.

Sleep and Ventilation
872Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database
Carolina Lombardi; Gianfranco Parati; Davide Soranna; Antonella Zambon; Paweł Sliwinski; Gabriel Roisman; Jean-Louis Pepin; Sophia Schiza; Renata Riha; Pavol Joppa; Ingo Fietze; Jan Hedner; Ludger Grote; the European Sleep Apnoea Database (ESADA) Collaborators
10.1111/resp.13760

The link between PLMS and cardiovascular alterations is still debated. Our current study aimed to address the effects of PLMS on BP in a large unselected OSA patient cohort, showing that the PLMS phenotype is associated with significantly elevated clinical SBP independent of confounders.

POSITION STATEMENT
880Respiratory management of infants with chronic neonatal lung disease beyond the NICU: A position statement from the Thoracic Society of Australia and New Zealand
Nitin Kapur; Gillian Nixon; Philip Robinson; John Massie; Bernadette Prentice; Andrew Wilson; Sandra Schilling; Jacob Twiss; Dominic A Fitzgerald
10.1111/resp.13876
SCIENTIFIC LETTER
889Foetal growth restriction and asthma: Airway smooth muscle thickness rather than just lung size?
Kimberley C W Wang; Peter B Noble
10.1111/resp.13851
CORRESPONDENCES
892Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease
Kinnosuke Matsumoto MD; Yuichi Adachi MD; Takatoshi Enomoto MD
10.1111/resp.13786
892Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease – Reply
Haruki Kobayashi MD
10.1111/resp.13785
894Face masks for community use: An awareness call to the differences in materials
Bernardo Sousa-Pinto MD, PhD; Ana Paula Fonte Eng; Antónia Andrade Lopes Eng; Bruno Oliveira MSc; João Almeida Fonseca MD, PhD; Altamiro Costa-Pereira MD, PhD; Osvaldo Correia MD, PhD
10.1111/resp.13891
895Universal public mask wear during COVID-19 pandemic: Rationale, design and acceptability
Christopher Liu OBE, FRCOphth, FRCSEd, FRCP, CertLRS Rawya Diab MBBS, MD, MRCSEd, FICO; Hasan Naveed MBBS, BSc (Hons); Victor Leung MSc, CIH, ROH, CRSP
10.1111/resp.13892
897Universal face masking in community: Material, design, and considerations—reply
Anthony P Sunjaya MD, SM; Christine Jenkins AM, MD, FRACP
10.1111/resp.13905
898National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19
Risa Ebina-Shibuya MD, PhD; Nobuyuki Horita MD, PhD; Ho Namkoong MD, PhD; Takeshi Kaneko MD, PhD
10.1111/resp.13885
899Reply
Wei-Jie Guan PhD; Nan-Shan Zhong MD
10.1111/resp.13882
LETTERS FROM ASIA-PACIFIC AND BEYOND
900A letter from the United States: A New York experience with COVID-19
Edward J Schenck MD; Meredith L Turetz MD; Michael S Niederman MD
10.1111/resp.13893
903Letter from Denmark
Celeste Porsbjerg Professor, PhD, MD
10.1111/resp.13793

Inside Respirology Case Reports

Respirology Case Reports, Volume 08 Issue 6

Show / Hide
Case Series
High-dose, short-term corticosteroids for ARDS caused by COVID-19: a case series
Clara So, Shosei Ro, Manabu Murakami, Ryosuke Imai, Torahiko Jinta
DOI: 10.1002/rcr2.596

Many questions on the clinical management of coronavirus disease (COVID-19) remain unanswered, and data on corticosteroid therapy as a choice of treatment are mixed. We present the clinical course of seven patients, review the previous evidence, and discuss management.

What happens when we treat the "Typhoid Mary" of COVID-19
Boon Hau Ng, Nik Nuratiqah Nik Abeed, Mohamed Faisal Abdul Hamid, Chun Ian Soo, Hsueh Jing Low, Yu-Lin Andrea Ban
DOI: 10.1002/rcr2.604

We describe the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia patterns in asymptomatic individuals. The common computed tomography (CT) thorax patterns found are peripheral ground-glass opacification (GGO) with upper or lower lobe predominance. We believe screening for 2019-novel coronavirus (COVID-19) in high-risk individuals may help identify the patients needing longer follow-up.

Case Reports
Use of pleural cryobiopsy for tissue culture specimens: a case report
Satoru Ishii, Manabu Suzuki, Hirokazu Arai, Jin Takasaki, Masayuki Hojo, Haruhito Sugiyama
DOI: 10.1002/rcr2.593

We present the case of a 43-year-old man with suspected tuberculous pleurisy (TP). Thoracoscopy under local anaesthesia showed the entire pleura with scattered nodules. Nodules were biopsied by conventional biopsy forceps, but the tissue sample was small, so a cryobiopsy was performed. Histological analysis of the conventional biopsy forceps and cryobiopsy specimen showed inflammation with lymphocytes and caseating granulomas. Tissue culture of conventional biopsy forceps was positive for Mycobacterium tuberculosis , and all sensitivity tests were positive. But, the tissue culture of the cryobiopsy sample was negative. There is a possibility that cryobiopsy is not useful for tissue culture for TP.

Endobronchial tuberculosis polyps
Christiaan Yu, Chuan Tai Foo, Ar Kar Aung, Simon A Joosten
DOI: 10.1002/rcr2.595

We present a patient with endobronchial tuberculosis (TB) polyps for which initial acid-fast bacilli staining and TB complex DNA polymerase chain reaction yielded negative results. Histopathology showed non-caseating granulomatous inflammation and the diagnosis was ultimately achieved four weeks later when bronchial washing cultures yielded Mycobacterium tuberculosis , thus highlighting the challenges in achieving a timely diagnosis.

Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy
Hao-Chun Chang, Chia-Lin Hsu, Yih-Leong Chang, Chong-Jen Yu
DOI: 10.1002/rcr2.597

Adenocarcinoma (ADC) is the most common form of lung cancer; however, some other types of lung cancer, such as pulmonary pleomorphic carcinoma (PC), can sometimes mimic ADC. Here, we present a patient with initial diagnosis of pulmonary ADC later diagnosed with PC.

Multisystem Langerhans cell histiocytosis in an adult non-smoker treated with steroid therapy
Haruka Ito, Masaru Ito, Yukio Kakuta, Takeshi Kaneko, Koji Okudera, Takashi Ogura
DOI: 10.1002/rcr2.603

Multisystem Langerhans cell histiocytosis in an adult non-smoker treated with steroid therapy for a subacute exacerbation: a case report and review of the literature.

Massive atelectasis by mucoid impaction in an asthma patient during treatment with anti-interleukin-5 receptor antibody
Takayuki Takimoto, Tomoko Kagawa, Kazunobu Tachibana, Toru Arai, Yoshikazu Inoue
DOI: 10.1002/rcr2.599

We herein report a case of a patient who developed massive atelectasis by mucoid impaction during treatment with anti-interleukin (IL)-5 receptor antibody.

Tuberculosis-associated chylothorax revealing an enlarged lymphatic duct due to tuberculosis lymphadenitis
Kojiro Honda, Takeshi Saraya, Chika Miyaoka, Kazuharu Suda, Masachika Fujiwara, Haruyuki Ishii
DOI: 10.1002/rcr2.600

We report a case of chylothorax due to tuberculosis lymphadenitis with distinct evidence of enlarged lymphatic duct macroscopically.

Recurrent hypertrophic pulmonary osteoarthropathy in an adult with bronchiectasis
Amelia Tekiteki, William R Good, Benjamin Diggins, Graeme Anderson, Conroy A Wong
DOI: 10.1002/rcr2.602

We describe a case of an adult patient with bronchiectasis and hypertrophic pulmonary osteoarthropathy (HPOA), whose joint symptoms flared during pulmonary exacerbations and improved with treatment of each exacerbation.

Sarcoidosis presenting as hiccups
Melissa Neumann, Kevin G Lazo, Diane Stover
DOI: 10.1002/rcr2.605

Hiccups caused by sarcoidosis have rarely been reported. We present an unusual case of sarcoidosis presenting with persistent hiccups that we believe is caused by his hilar and mediastinal lymph node enlargement.

A foreign body experience
David Ferreira, Yashneel Prasad, Hima Vedam, Melissa Baraket, Sayontonee Ghosh, Jonathan P Williamson
DOI: 10.1002/rcr2.606

Foreign body inhalation (FBI) is an uncommon clinical entity in adults and is a potentially serious but treatable condition. The authors report a case of a 31-year-old female asthmatic who presented with FBI. A non-organic object was removed with rigid bronchoscopy and a cryoprobe with resolution of symptoms.

Successful treatment of telomeropathy-related interstitial lung disease with immunosuppression and danazol
Daniel C Chambers, Viviana P Lutzky, Simon H Apte, David Godbolt, John Feenstra, John Mackintosh
DOI: 10.1002/rcr2.607

Genomic contributors to the pathogenesis of interstitial lung disease are increasingly recognized. This case report describes dramatic clinical response to a combination of immunosuppression and danazol in a patient with non-specific interstitial pneumonia associated with very short telomeres.

Mycobacterium avium pleuritis with multiple nodules in the pleura
Hiroaki Ogata, Eiji Harada, Tomoaki Takao, Kayo Ijichi, Naoki Hamada, Koichiro Matsumoto
DOI: 10.1002/rcr2.608

Pleurisy hardly develops in patients with nontuberculous mycobacteria (NTM) infection. We report the first case of NTM pleuritis with multiple granulomatous nodules in the pleura.

Tracheobronchopathia osteochondroplastica: rare but not to be forgotten
Fahad Gul, Eric Peterson, Robert Dejoy III, Glenn Eiger, Andres Mora Carpio, Ena Gupta
DOI: 10.1002/rcr2.609

We report a case of a 59-year-old male with a one-month history of pleuritic chest pain who was diagnosed with tracheobronchopathia osteochondroplastica (TO). TO is a rare benign condition characterized by protruding submucosal nodules into the tracheobronchial lumen. We hope this case will help to increase physician and patient awareness about this disease to help improve diagnostic strategy and knowledge of disease manifestations and potential complications.

Birt–Hogg–Dubé syndrome presenting with macroscopic pulmonary cyst formation in a 15-year-old
Luke Ardolino, Elizabeth Silverstone, Vincent Varjavandi, Deborah Yates
DOI: 10.1002/rcr2.610

Birt–Hogg–Dubé syndrome is a rare, autosomal dominant disorder characterized by benign skin lesions, renal tumours, and pulmonary cysts. Individuals with this syndrome have a sevenfold increase in their risk of renal cancers and over 80% will develop pulmonary cysts, of which ~30% will experience a spontaneous pneumothorax in their lifetime.

Spontaneous remission of the micronodular pattern in cryptogenic organizing pneumonia
Naoki Kawakami, Rina Kato, Chushu Liu, Masaru Ito, Yoko Wakai, Kazuhito Saito
DOI: 10.1002/rcr2.611

Herein, we report a case of a diffuse micronodular form of cryptogenic organizing pneumonia (COP) that was diagnosed via transbronchial biopsy (TBB) and resolved spontaneously within a few months. Our case highlights that diffuse micronodular pattern of OP (MNOP) may resolve spontaneously similar to other forms of OP, and mild cases may be under-recognized. Furthermore, careful observation could be an option for managing MNOP with mild and non-progressive symptoms.

Unilateral pleural effusion with capillary haemangioma
Nozomi Kadota, Manabu Murakami, Ryosuke Imai, Torahiko Jinta, Tomohide Tamura
DOI: 10.1002/rcr2.613

Here, we report a case of haemangioma on middle mediastinum accompanied by unilateral pleural effusion, which was initially suspected to be lung cancer and pleurisy. Although mediastinal haemangioma is hard to diagnose without surgery, we should include it in the differential diagnosis of a tumour with unilateral pleural effusion.

Localized circumferential narrowed bronchial wall lesions in allergic bronchopulmonary aspergillosis
Yurina Murakami, Yoshihiro Kitahara, Tomohiro Uto, Jun Sato, Shiro Imokawa, Takafumi Suda
DOI: 10.1002/rcr2.612

The typical bronchial manifestations of allergic bronchopulmonary aspergillosis (ABPA) include intraluminal retention of inspissated mucus plugging and chronic inflammation of airway walls with eosinophils, lymphocytes, and neutrophils. Bronchiectasis and bronchial wall thickening can be seen on chest computed tomography (CT) scans. However, localized circumferential narrowing of the bronchus has not been reported. Herein, we report such a patient with ABPA, whose bronchial lesions disappeared after treatment with prednisolone and antifungal agents.

Aggressive lung involvement in a patient with T-acute lymphoblastic leukaemia/lymphoblastic lymphoma: a tricky and rare case report
Chika Miyaoka, Takeshi Saraya, Kojiro Honda, Masachika Fujiwara, Haruyuki Ishii, Hajime Takizawa
DOI: 10.1002/rcr2.614

Herein, we described an extremely rare case of T-ALL/LBL accompanied by massive lung involvement without lymphoblasts in the blood.

Visceral pleural biopsy under medical thoracoscopy for the diagnosis of lung adenocarcinoma
Satoshi Terashita, Keiichiro Suminaga, Hiroaki Kawachi, Susumu Noguchi, Tatsuyoshi Ikeue, Takakazu Sugita
DOI: 10.1002/rcr2.616

In this study, we report a rare case of the successful diagnosis of lung adenocarcinoma, based on the findings of visceral pleural biopsy under medical thoracoscopy.

Uveitis developing in tuberculous lymphadenitis-associated Behçet's disease during anti-tuberculosis therapy
Saeko Takahashi, Kotaro Otomo, Yoko Kawakami, Morio Nakamura
DOI: 10.1002/rcr2.617

We present the first report of uveitis developing two months after starting tuberculosis (TB) treatment in a 46-year-old woman with tuberculous lymphadenitis presenting with oral and genital ulcers and erythema nodosum-like lesions on diagnosis of TB. The appearance of uveitis was attributed to a paradoxical reaction in TB because of simultaneous relapse of lymphadenopathy and retinal findings on fluorescein angiography. Although rare, physicians should be aware that ocular involvement can occur during anti-TB therapy, most likely with extrapulmonary TB, because ocular involvement may decrease patient quality of life if visual symptoms become irreversible with delayed diagnosis and treatment.

Pulmonary large cell neuroendocrine carcinoma with adrenal oligorecurrence successfully treated by adrenalectomy
Hiroki Sato, Motoko Tachihara, Tatsunori Kiriu, Masatsugu Yamamoto, Yugo Tanaka, Yoshihiro Nishimura
DOI: 10.1002/rcr2.618

We report a case of large cell neuroendocrine carcinoma (LCNEC) with adrenal gland oligorecurrence treated by adrenalectomy, which led to long-term survival.

Clinical Image
Mediastinal malignant mesothelioma discovered in a patient with dysphagia
Dario Amore, Simona Massa, Umberto Caterino, Dino Casazza, Albina Palma, Carlo Curcio
DOI: 10.1002/rcr2.592

A mediastinal mass in patients with a history of asbestos exposure should raise the suspicion of malignant mesothelioma.

Complete occlusion of right pulmonary artery in Behçet disease
Yohei Korogi, Nozomi Tanaka, Hajime Yoshifuji, Junichi Tazaki, Takeshi Kubo, Kiminobu Tanizawa
DOI: 10.1002/rcr2.594

Here, we describe a case of complete occlusion of right pulmonary artery seen in a patient with Behçet disease.

Left pulmonary artery pseudoaneurysm secondary to post-operative lung abscess
Dario Amore, Giorgio Bocchini, Dino Casazza, Umberto Caterino, Albina Palma, Carlo Curcio
DOI: 10.1002/rcr2.598

We report a rare case of post-operative pulmonary artery pseudoaneurysm. In such instance a prompt diagnosis and adequate treatment are essential to avoid catastrophic complications.

Accessory V6 during thoracoscopic middle lobectomy: "an uncomfortable presence"
Dario Amore, Roberto Scaramuzzi, Dino Casazza, Pasquale Imitazione, Emanuele Muto, Roberta Lieto
DOI: 10.1002/rcr2.601

We report a patient in whom a supernumerary venous branch draining the superior segment of the right lower lobe into the left atrium (accessory V6) was accidentally discovered near the level 7 nodal packet thus avoiding complications during surgery. The anomalous vessel was retrospectively identified on chest computed tomography (CT) scan.

Second SVC stent treatment for tumour ingrowth
Yutaka Takahara, Yoko Ishige, Ikuyo Shionoya, Yuki Fujimoto, Taku Oikawa, Shiro Mizuno
DOI: 10.1002/rcr2.619

This is a case of lung cancer with recurrent superior vena cava (SVC) syndrome, which was treated with additional stent placement.

Respirology Case Reports, Volume 08 Issue 7

Show / Hide
Case Reports
Bronchial varices in a child with tricuspid atresia six years post Fontan correction
Shreya Bhushan, Vikas Goyal, Cameron Ward, Muddassir Rashid, Nitin Kapur
DOI: 10.1002/rcr2.620

Tracheal and bronchial varices are rare, especially in children. We report the first presentation of bronchial varices and haemoptysis in a child, six years after a Fontan procedure for tricuspid atresia. She had tortuous mediastinal and transpleural arterial collaterals on imaging and subsequently underwent embolization of these collaterals with haemoptysis settling after this.

Indwelling pleural catheter and successful autopleurodesis of refractory inflammatory lupus effusion
Boon Hau Ng, Nik Nuratiqah Nik, Abeed Mohamed Faisal Abdul Hamid, Chun Ian Soo, Hsueh Jing Low, Andrea Yu-Lin Ban
DOI: 10.1002/rcr2.621

Indwelling pleural catheter (IPC) is a useful tool for refractory malignant pleural effusions (MPEs). Its use in benign pleural effusions comes mainly from retrospective studies, case series, and case reports. Lupus effusion is common, causes minimal symptoms, and usually responds to either steroid therapy or immunosuppressants. We describe a 52-year-old woman whose first presentation of systemic lupus erythematosus (SLE) was a pleural effusion refractory to steroids and immunosuppressants. She successfully achieved spontaneous pleurodesis with intermittent IPC drainage at three months.

A case of non-severe COVID-19 complicated by pulmonary embolism
Yuto Akiyama, Kohei Horiuchi, Yasushi Kondo, Hiroki Kabata, Makoto Ishii, Koichi Fukunaga
DOI: 10.1002/rcr2.622

Here, we report a case of non-severe coronavirus disease 2019 (COVID-19) complicated by pulmonary embolism (PE), which indicates that the possibility of PE should consistently be considered, even in non-severe cases of COVID-19 without any risk of thrombosis.

Resolution of refractory chylothorax with a combination of talc pleurodesis and CPAP
Boon Hau Ng, Nik Nuratiqah Nik Abeed, Mohamed Faisal Abdul Hamid, Chun Ian Soo, Hsueh Jing Low, Andrea Yu-Lin Ban
DOI: 10.1002/rcr2.624

We describe a 69-year-old woman with underlying diffuse large B-cell lymphoma of the colon 16 years ago in remission, who presented with a new problem of refractory chylothorax. It was successfully treated with continuous positive airway pressure (CPAP) ventilation in tandem with talc pleurodesis.

Advanced G-CSF -producing non-small cell lung cancer-not otherwise specified, with favourable response to pembrolizumab monotherapy
Yohei Matsui, Tadaaki Yamada, Naoko Masuzawa, Shinshichi Hamada, Koichi Takayama, Osamu Hiranuma
DOI: 10.1002/rcr2.625

Here, we report a patient with non-small cell lung cancer-not otherwise specified (NSCLC-NOS) with high PD-L1 expression and aberrant granulocyte colony-stimulating factor (G-CSF) production, in whom monotherapy with the anti-PD-1 antibody pembrolizumab was effective as an initial treatment.

Incomplete metalloptysis linger pneumonia after a wedge resection of the lung for organizing pneumonia
Sen-Ei Shai, Yi-Ling Lai, Hsiao-Wen Tang, Shih-Chieh Hung
DOI: 10.1002/rcr2.627

e00627 First Published: 16 July 2020 We report the first case of incomplete metalloptysis linger pneumonia after the wedge resection of organizing pneumonia, with complete recovery by removal of residual clips, where clips from the staple cartridges had been applied on the periphery of the lung migrated and been incompletely expectorated.

Thrombocytopaenia during nintedanib treatment in a patient with idiopathic pulmonary fibrosis
Yusuke Ochi, Motoyasu Kato, Masahiro Fujioka, Mika Hayashi, Haruhi Takagi, Kazuhisa Takahashi
DOI: 10.1002/rcr2.628

We present a rare case of symptomatic thrombocytopaenia associated with nintedanib treatment in a patient with idiopathic pulmonary fibrosis (IPF).

Clinical Image
Multiple patchy pulmonary consolidation in granulomatosis with polyangiitis
Masahiro Yamasaki, Masaya Taniwaki, Shota Nakano, Naoko Matsumoto, Shinji Nabeshima, Noboru Hattori
DOI: 10.1002/rcr2.623

e00623 First Published: 15 July 2020 Multiple patchy pulmonary consolidations that are unresponsive to antibiotics and/or exist at peri-bronchial sites and bloody bronchoalveolar lavage may effectively help clinicians diagnose granulomatosis with polyangiitis.

Regional society news

The spotlight this month is on

PHILIPPINES

Each month we share details of activities of a particular country, region or society.

If you would like the spotlight to be on your country, region or society next month, contact the Bulletin Coordinator or APSR Secretariat.

An APSR-PCCP Joint Symposium was held during the 39th Annual Chest Convention of the Philippine College of Chest Physicians (PCCP) on 4 March 2020 at Edsa Shangrila, Manila, Philippines.

As with all En Bloc Society - APSR Joint Symposia half of the lectures were presented by the En Bloc Society and half from the APSR.

Programme:

4 March 2020 11:00-11:30
Master plenary session 4
President's session
• Malbar G Ferrer, MD, FPCCP (PCCP)
• Kwun Fong, MD (APSR)
• Mark Elliott, MD (BTS)
6 March 2020 10:20-10:50
Master plenary session 9
Advances in lung cancer - diagnosis & treatment
• Kwun Fong, MD

Dr Fong reports:

It was a privilege and honour to represent the APSR at the outstanding PCCP 39th Annual Chest Convention: 3-6 March 2020 in Manila with a very interesting theme of "CLARITY: Concepts, Lessons, Advances and Realities in the year 2020".

The Local Organising Committee did a remarkable job and delivered a very high quality meeting full of scientific and educational content. Congratulations and thanks to them and the PCCP for strengthening the close relationship with the two Societies.

It was a 3-day programme with Plenaries, Meet the Masters, Exhibits, Oral and poster presentations, intertwined with official functions and social events. The PCCP is renowned for delivering quality research and education while extending collegiate and networking opportunities, and this was fully evident at "Clarity". The full majesty and formality of the Opening Ceremony with an Honour Lecture by Dr Jennifer Ann Mendoza-Wi set the scene for a wonderful Convention.

The Plenaries included topics on the Big 5 of lung disease; asthma, COPD, infection, lung cancer and TB, with excellent speakers from local, regional, national and international sources. Technological innovations were impressive with live streamed presentations including on the topic COVID-19 soon to be pandemic.

The interhospital debates were robust and served to showcase new talent which bodes well for respiratory medicine in the Philippines.

Well done PCCP members, keep up your remarkable work and help us all in the Asia-Pacific region reach out and help our communities achieve the good lung health that we all deserve. Salamat.

The PCCP reports:

As launched in the APSR Hanoi last November 2019, the Philippine College of Chest Physicians (PCCP) immediately applied for the innovative project "Joint APSR - En bloc Society Symposium", as an added feature in our annual meeting scheduled on 3-6 March 2020 in Manila, Philippines. We were honoured to have Prof. Kwun M Fong, the immediate past president of the APSR, as the faculty who represented the Society in our meeting.

Prof. Fong's first symposium was the Presidents' Session where along with the two other panelists, Dr Malbar Ferrer, incumbent president of the PCCP and Dr Mark Elliott, immediate past president of the British Thoracic Society (BTS), discussed on how the different respiratory societies can collaborate and work together to address the biggest challenges facing the medical field right now. The session, facilitated by Dr Patrick Moral, a member of the APSR Education Committee, tackled climate change, COVID-19, the opportunities and dangers of social media in respiratory medicine, approach to diverse organizations in terms of culture and the societies impact in members' clinical practice. Prof. Fong shared a notable message for the societies to work things locally and achieve globally.

Another Joint APSR-PCCP Symposium conducted was the plenary session on "Advances in Lung Cancer Diagnosis and Treatment" where Prof. Fong presented the current approach to diagnosis and treatment options for lung cancer.

As an offshoot of the successful 2020 PCCP CLARITY Annual Chest Convention, another great initiative was launched by the APSR, the APSR-PCCP Travel Award in APSR Congress. Maiden conferment was originally planned for the 2020 Kyoto APSR Congress, derailed by the current pandemic.

The PCCP conveys its sincerest gratitude to the Executive Committee of the Asian Pacific Society of Respirology for giving us the opportunity to host these significant sessions. The convention was an unqualified success as measured by attendance and quality of the scientific programme.

(Click any image to enlarge)



left to right: Dr Patrick Gerard Moral, session chair, Dr Malbar Ferrer, PCCP President 2019-20, Dr Gwen Dy-Agra, chair, scientific committee, Dr Mark Elliott, British Thoracic Society president, Dr Kwun Fong, APSR immediate past president and Dr Imelda Muriel-Mateo, overall chair of the PCCP 2020 Annual Chest Convention.


left to right: Dr Ivan Villespin, PCCP president 2020-21, Dr Kwun Fong, APSR immediate past president and convention faculty, Ms Joan Cala-Silva, PCCP administrative officer and Dr Gregorio Ocampo, PCCP vice president 2020-21.

To hold a joint APSR session with your own respiratory society, see apsresp.org/education/joint-symposium.html

Other regional news:

China

The date has changed for the World Congress of Bronchology & Interventional Pulmonology (WCBIP), biennial flagship international congress of the WABIP (World Association of Bronchology & Interventional Pulmonology).

This had been scheduled to be held in Shanghai, China, on 16-19 April 2020 and has been postponed to 24-27 September 2020 due to the coronavirus pandemic.

Please check the WABIP webpage www.wabip.com/congress for the latest details.

Japan

The date has changed for the 60th Annual Meeting of the Japanese Respiratory Society

This had been scheduled to be held in Nagoya on 24-26 April 2020 and has been postponed to 20-22 September 2020 due to the coronavirus pandemic. The venue has also been changed and the Annual Meeting will now be held at the Kobe Convention Center, Japan.

Please check the JRS webpage www.jrs.or.jp/jrs60/en/index.html for the latest details.

Singapore

Due to the pandemic, the date of the World Conference on Lung Cancer has changed.

This had been scheduled to be held on 9-12 August 2020 and has been postponed to 26-29 January 2021.

Please check the IASLC website wclc2020.iaslc.org for the latest details.

Health news

World Lung Cancer Day

Respiratory groups stress lung cancer risks and importance of early screening and treatment

Tokyo, 1 August 2020









In support of World Lung Cancer Day, the Forum of International Respiratory Societies (FIRS), of which the APSR is a founding member, calls for more awareness and understanding of lung cancer risk factors, as well as the importance of early screening and treatment.

Lung cancer is responsible for nearly 1 in 5 cancer deaths according to the World Health Organization. While lung cancer and breast cancer are diagnosed at the same rate (11.6 percent), lung cancer kills more people yearly than breast, colon and prostate cancers combined. Lung cancer mortality is projected to reach 2.45 million by 2030, a 39 percent increase in just over a decade.

While most understand that smoking is the single greatest risk factor for lung cancer at 80 percent of all cases, other lesser known risk factors include the environment and genetics. Environmental exposure to radon, asbestos, arsenic, beryllium and uranium has been linked to lung cancer. The risk of lung cancer also increases with a history of cancer in another part of the body, age, family history, radiation to the chest area and lung diseases like chronic obstructive pulmonary disease (COPD).

Access to screening options and education is vital for early detection and treatment. Low-income countries, where survival rates are significantly below the average, report only a 15 percent availability of treatment through public health systems. More that 90 percent of high-income countries report vital access to care.

Lung cancer symptoms include change in mucus, chest or back pain, coughing up blood and difficulty swallowing. Tests that may be used to diagnose lung cancer include chest x-rays, CT and PET scans, bronchoscopy and needle biopsies. If you are a current or former smoker and over the age of 55, you may be a candidate for a low-dose CT scan screening that can potentially detect lung cancer in its earliest stages.

About the Forum of International Respiratory Societies (FIRS)

Click any of the images above to enlarge (poster size) and copy for your activities.

You can also click any of the blank templates below for creating posters with your own message. Feel free to add your society logo at the bottom.

Lung Cancer 2020 Fact Sheet

Lung cancer: the most fatal cancer

  • The most frequently diagnosed cancer is lung cancer (11.6 percent), followed by female breast (11.6 percent) and colorectal cancers (10.2 percent).
  • Worldwide lung cancer incidents are on track to increase by 38 percent to 2.89 million by 2030.
  • Lung cancer is the leading cause of death from cancer at 1.74 million (18.4 percent), followed by colorectal (9.2 percent) and stomach cancers (8.2 percent).
  • Lung cancer deaths exceed breast cancer mortality for women in 28 countries.
  • Lung cancer mortality is projected to reach 2.45 million worldwide by 2030, a 39 percent increase since 2018.
  • About 80 percent of lung cancer deaths are as a result of smoking tobacco. Smokers exposed to other known risk factors such as radon and asbestos are at an even higher risk.
  • For men, lung cancer is the most prevalent form of cancer, it is third for women.
  • The five-year cancer survival rate in middle-income countries for all types of lung cancer (19 percent) is lower than many other leading cancer sites, such as the colon (71 percent), breast (85 percent) and prostate (98.9 percent).

Treating lung cancer

  • In lower-income countries, access to care and cost-effective treatments can reduce the human burden and societal impact of lung cancer.
  • Screening with CT scans compared with chest radiography resulted in a 20 percent reduction in lung cancer-specific deaths, but much cheaper and more accessible methods are needed for low-income settings.
  • Early-stage lung cancer is treated with curative-intent surgery or radiation therapy.
  • Selective patients may benefit from chemotherapy after surgical resection, while patients with local advanced disease may benefit from concurrent chemo-radiotherapy with or without surgery.
  • Although advanced stage lung cancer is not curable, many patients may have symptom improvement and survival prolongation by effective treatment.
  • Molecular-targeted therapy against epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) re-arrangements attain tumor response rates of around 70 percent.

World Lung Day

Advance notice for your preparations for World Lung Day on 25 September

The Forum of International Respiratory Societies (FIRS) have prepared a series of fliers in different languages.

Click any image to enlarge and copy.

Education

Teaching Library

The Teaching Library is open for your self-study. Challenging yourself to choose the correct procedure for any of the 111 cases in the Library at apsresp.org/education/teaching-library/index.php.

Many more cases are needed for this Library and any member is welcome to submit a case through the same link as above.

New educational article

The following article has recently been selected from Respirology for its specific educational value. Previous articles on further topics can be seen at apsresp.org/education/articles/index.html


Figure 1 of 10.1111/resp.13760
(Click image to enlarge)

Of special interest to those working in:
* Sleep
* Pulmonary circulation
* Clinical Respiratory Medicine

Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database Carolina Lombardi; Gianfranco Parati; Davide Soranna; Antonella Zambon; Paweł Sliwinski; Gabriel Roisman; Jean-Louis Pepin; Sophia Schiza; Renata Riha; Pavol Joppa; Ingo Fietze; Jan Hedner; Ludger Grote; the European Sleep Apnoea Database (ESADA) Collaborators (DOI: 10.1111/resp.13760)
onlinelibrary.wiley.com/doi/10.1111/resp.13760/full (May 2020)

Comment by Dr Mark Lavercombe:
The association between obstructive sleep apnoea and cardiovascular disease is well recognised. In this paper, the authors explore the role of comorbid elevation of the periodic limb movements in sleep index in a cohort of of patients with obstructive sleep apnoea, and demonstrate a significant elevation in systolic blood pressure, even after accounting for the degree of OSA with multivariate analysis. Further studies - including those utilising 24h BP monitoring - are recommended.

APSR Membership

Donations received

The following members have kindly sent their donation towards the Society's goals, as outlined at apsresp.org/members/donors.php.

  • Dr Sateesh Sakhamuri FAPSR
  • Dr Alvin Kosasih FAPSR

The APSR is profoundly grateful for their generosity.

Dr Yuanlin Song

Dr Song, Head of the APSR Respiratory Infections (non-tuberculous) Assembly, has been invited to participate in ATS Virtual 2020 5-10 August 2020, along with other experts representing the ATS, ERS, ALAT and PATS.

There will be two 90-minute sessions 'Global Review on COVID-19':

5 August at 08:30 (US Eastern Time)

  • Introduction
    Samya Nasr (USA)
  • Global perspective on COVID Epidemiology:
    David Dowdy (USA)
  • Asian perspective:
    Yuanlin Song (China)
  • European perspective:
    Tobias Welte (Germany)
  • USA perspective:
    Gabriel C Lockhart (USA)

10 August at 08:30 (US Eastern Time)

  • Introduction
    David Lewinsohn (USA)
  • Balancing the Economy and Public Health:
    Alex van Der Heever (South Africa)
  • South Americn perspective:
    Karen Czischke (Chile)
  • African perspective:
    Refiloe Masekela (South Africa)
  • Round Table Discussion:
    Moderators: Richard van Zyl Smit (South Africa), and Gustavo Zabert (Argentina)

For the start times and further details see ATS Virtual 2020.

APSR Young Investigator Awardees at the ERS Congress (virtual) 2020

Dr Tatsuma Fukuda will present during the session 'New insights into mechanical ventilation in the intensive care unit' on 7 September at 09:30-10:30.

Dr Shu-Yung Lin will present during the session 'Tuberculosis' on 8 September at 14:30-15:30.

Congratulations to both members and we are confident their presentations of their work will be greatly appreciated by their audiences.

New Fellows of the APSR

Congratulations to the following members who have recently become Fellows of the APSR:

  • Dr Sateesh Sakhamuri FAPSR
  • Dr Alvin Kosasih FAPSR

New and updated assembly memberships

A warm welcome to the following members who have recently joined or re-joined APSR assemblies.

Harender Singh ChaudharyClinical Respiratory Medicine
Tuberculosis
Clinical Allergy & Immunology
Chi-Li ChungClinical Respiratory Medicine
Lung Cancer
Interstitial Lung Disease
Laxmi DeviClinical Respiratory Medicine
Tuberculosis
Asthma
Andrew Charles FreanEnvironmental & Occupational Health and Epidemiology
Respiratory Infections (non-tuberculous)
Asthma
Mansoor HameedAsthma
Clinical Respiratory Medicine
COPD
Rahul JalanBronchoscopy and Interventional Techniques
Tuberculosis
Interstitial Lung Disease
Niranjan Chandrama Lehupe BandarageClinical Respiratory Medicine
Interstitial Lung Disease
Respiratory Infections (non-tuberculous)
Abdullah MobeireekClinical Respiratory Medicine
Respiratory Infections (non-tuberculous)
Respiratory Infections (non-tuberculous)
Avinash MuruganBronchoscopy and Interventional Techniques
Critical Care Medicine
Interstitial Lung Disease
Manju RajaramClinical Respiratory Medicine
Cell and Molecular Biology
Interstitial Lung Disease
Venkateswara Babu RanganathanClinical Allergy & Immunology
COPD
Asthma
Krishna K SharmaPulmonary Circulation
Interstitial Lung Disease
Bronchoscopy and Interventional Techniques
Anoma Siribaddana Interstitial Lung Disease
Environmental & Occupational Health and Epidemiology
Respiratory Neurobiology and Sleep
Rishikesavan SuntharalingamRespiratory Neurobiology and Sleep
Lung Cancer
Interstitial Lung Disease
Mahesh Babu VemuriClinical Respiratory Medicine
Respiratory Infections (non-tuberculous)
Interstitial Lung Disease
Sugeesha Wickramasinghe Clinical Respiratory Medicine
Critical Care Medicine
Interstitial Lung Disease
Siti Chandra WidjanantieEnvironmental & Occupational Health and Epidemiology
Respiratory Structure and Function
COPD
Rex Chin-wei YungCritical Care Medicine
Lung Cancer
Bronchoscopy and Interventional Techniques

Future Pulmonology Events

Here are the main respiratory events in Asia-Pacific region for the next few months. You can see our full listing on the APSR Calendar.

  • 60th Annual Meeting of the Japanese Respiratory Society
    20-22 September 2020, online
    (Details)
  • World Congress of Bronchology & Interventional Pulmonology (WCBIP)
    24-27 September 2020, Shanghai, China
    (Details)
  • The 16th National Congress Indonesian Society of Respirology in conjunction with 1st Indonesia Chronic Lung Disease International Meeting (ICLIME)
    23-26 September 2020, Makassar, Indonesia
    (Details)
  • Scientific conference with updates from The Congress of European Respiratory Society (ERS) 2020 (VNRS)
    25-26 September 2020, Hanoi, Vietnam
    (Details)
  • Congress of International Lung Health and World COPD Day 2020 (VNRS)
    5-7 November 2020, Hanoi, Vietnam
    (Details)
  • 130th Conference of the Korean Academy of Tuberculosis and Respiratory Diseases (KATRD)
    12–13 November 2020, Seoul, Republic of Korea
    (Details)
  • Annual Congress of Vietnam Respiratory Society 2020 (combination of VNRS Congress and Association Franco-Vietnamienne De Pneumologie) and Pre-congress Workshop on Bronchoscopy
    13-15 November 2020, Da Nang city, Vietnam
    (Details)
  • Asthma & COPD Outpatient Care Unit (ACOCU) Network Day
    15 November 2020, Ho Chi Minh City, Vietnam
    (Details)
  • Malaysian Thoracic Society (MTS) 2020 Annual Congress
    10-13 December 2020, Nusajaya, Johor, Malaysia
    (Details)
  • World Conference on Lung Cancer
    26-29 January 2021, Singapore
    (Details)

For more pulmonology events, see apsresp.org/calendar.html
(These events are for information only and APSR endorsement should not be assumed.)

Contact

If you have news of interest to APSR members, please send details to one of the Bulletin Coordinators: Prof. A Azuma (a-azuma@nms.ac.jp) or Prof. C K Rhee (chinkook77@gmail.com).


Click here to see previous issues of the Bulletin
If you prefer not to receive further APSR Bulletins, click unsubscribe
Comments: bulletin@apsresp.org or APSRinfo@theapsr.org
© Asian Pacific Society of Respirology